$LEA

Lear Corporation Stock 12‑Month Price Target Cut to $149, Implies 21% Upside

Analyst estimates for Lear Corporation show the average 12-month price target was cut to $149 from $150.5, with a range of $130 to $179 per share. Based on the Aug. 13 close, the target implies about 21% upside. The consensus rating remains “Buy” with 6 Buys, 12 Holds, and 0 Sells.

Original reporting
Published Aug 14, 2026, 7:20 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:17 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lear Corporation Stock 12‑Month Price Target Cut to $149, Implies 21% Upside — source image
Decision brief

The 30-second read

$LEANeutralLow
01

Why it matters

For traders, the actionable signal is the direction of analyst expectations (target down) while the rating stance remains supportive (no Sells).

02

Market read

Analyst target reduction may modestly affect sentiment, but the lack of new company fundamentals limits trading edge.

03

What to watch

The article lacks the underlying thesis for the target cut, so traders should not assume a fundamental deterioration without additional coverage.

Relevance 4/10Novelty 3/10Timing: pre-market today

Background

The piece summarizes FactSet-sourced analyst estimates: average 12-month price target and the distribution of Buy/Hold/Sell ratings.

Company-level read

Ticker impact

$LEANeutralMedium confidence
Context

Lear’s average 12-month analyst price target is cut from $150.5 to $149, with a $130 to $179 range and consensus still “Buy.”

Expected impact

Likely limited near-term impact unless the broader analyst rationale signals deteriorating fundamentals; watch for follow-on downgrades or thesis changes.

Evidence & confidence

The article provides only price-target and rating distribution changes, with no new Lear-specific operational or financial datapoint.

Market effects

Minimal, since the update is analyst-target related with no new sector-wide catalyst described.

None indicated.

None indicated.

Counterpoint

A lower average target can be offset by the still-positive consensus mix (6 Buys, 12 Holds), implying the market may already be pricing the change.

Key entities

  • Lear Corporation

    Subject of the article, with its average 12-month analyst price target reduced to $149 and consensus rating still “Buy.”

Related articles

$LEAMedAI 8/10

Lear (LEA) Is Down 6.0% After Hiking 2026 Guidance And Expanding Buybacks And Shelf Plans – Has The Bull Case Changed?

Lear Corp (NYSE:LEA) reported Q2 2026 results with sales of $6,209.4 million and net income of $192.8 million. The company raised full-year 2026 revenue guidance to about $23.8 billion, updated second-half operating income and margin expectations, expanded share buybacks, and filed new shelf registrations including an ESOP-related offering.

$LEAHighAI 9/10

Lear Q2 Earnings Call Highlights

Lear Corporation (NYSE:LEA) reported Q2 E-Systems sales up 2% to $1.6B, but organic sales down 2% due to lower volumes tied to certain Volkswagen and Ford Mustang Mach-E programs and Ford Escape, Focus and Corsair build-outs. Adjusted earnings rose to $91M, operating margin to 5.8%. Lear raised 2026 revenue to ~$23.8B and core operating earnings to ~$1.14B, plus FCF to ~$640M.

$LEAMedAI 8/10

Lear Corporation Q2 2026 Earnings Call Summary

Lear Corporation reported record first-half revenue above $12B, with 3% sales growth and margin expansion in E-Systems. It won $2.9B in YTD business awards, including major Audi seating. Lear raised 2026 guidance to $23.8B revenue and $1.14B core operating earnings, citing higher North American volumes and China weakness. It increased buybacks to at least $350M.

$LEAMed

Why is Lear stock tumbling today?

Lear Corp shares fell 10.5% to $130.99 after the company reported Q2 results and issued cautious forward guidance. Adjusted EPS was $4.28 vs $3.92 expected, and revenue rose to $6.2B vs $6.14B. Guidance for fiscal 2026 adjusted EBITDA was $1.7B to $1.82B, with China weakness and softer production outlook cited. A shelf registration filing was also reported.